Remarkable transformations in science and healthcare have resulted in declines in mortality
from cardiovascular disease over the past several decades, largely driven by progress in …

Objective: Phenolic compounds are essential for defense reactions, including antioxidant,
anti-inflammatory, antidiabetic, anti-proliferative activity, and anti-aging activity. Coming from …

Background: Secondary prevention lifestyle and pharmacological treatment of
atherosclerotic cardiovascular disease (ASCVD) reduce a high proportion of recurrent …

Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) provides an overview of the mechanisms and treatment of obesity and hypertension …

Atherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular
diseases. The progression of AS is a multi-step process leading to high morbidity and …

Cardiovascular diseases (CVDs) which consist of ischemic heart disease, stroke, heart
failure, peripheral arterial disease, and several other cardiac and vascular conditions are …

Background Body mass index (BMI or weight in kilograms/height in meters 2) is the most
common metric to diagnose overweight and obesity. However, a body composition analysis …

Chronic kidney disease (CKD) represents a significant global health challenge, affecting
millions of individuals and leading to substantial morbidity and mortality. This review aims to …

Cardiovascular disease (CVD) remains the leading cause of death and disability worldwide.
While many factors can contribute to CVD, atherosclerosis is the cardinal underlying …

Circulating cell-free DNA and its association with cardiovas... : Current Opinion in Lipidology
Circulating cell-free DNA and its association with cardiovascular disease: what we know and …